Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-22-009871
Filing Date
2022-04-14
Accepted
2022-04-14 06:15:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 1045302
  Complete submission text file 0001493152-22-009871.txt   1046374
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-252430 | Film No.: 22825939
SIC: 2834 Pharmaceutical Preparations